Wall Street Analysts Believe Editas (EDIT) Could Rally 80%: Here's is How to Trade

Shares of Editas Medicine (EDIT) have gained 0.7% over the past four weeks to close the last trading session at $8.15, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $14.67 indicates a potential upside of 80%.The average comprises 12 short-term price targets ranging from a low of $7 to a high of $27, with a standard deviation of $6.69. While the lowest estimate indicates a decl ...